For Investors

Press Releases

ReWalk Robotics Reports Second Quarter 2022 Financial Results

08/09/22

Highlights June 8 th Milestone Participation at Biannual CMS HCPCS   Public Meeting as Part of Efforts to Gain “Artificial Legs” Benefit Category Classification as Prosthetic for ReWalk Device          Has Submitted 510k A pplication for ReWalk Stairs and Curbs Functionality MARLBOROUGH, Mass.

ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022

08/03/22

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Aug. 03, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022 , at 8:30 AM Eastern time .

ReWalk Robotics Announces Results of 2022 Annual Meeting

08/02/22

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Aug. 02, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the results of the Company's

ReWalk Receives Court Approval for Share Repurchase Program

07/21/22

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , July 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that it has received Israeli

100th ReWalk Exoskeleton Supplied in Germany

06/23/22

21-year-old Lukas Gloßner from Nürnberg is the 100th paraplegic in Germany to be provided with a ReWalk Personal Exoskeleton BERLIN , June 23, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd (Nasdaq: RWLK) ("ReWalk" or "the Company"), a leading manufacturer of robotic medical technology for people

ReWalk Provides Notice of 2022 Annual Meeting of Shareholders

06/10/22

Annual Meeting Will be Held on July 27, 2022 MARLBOROUGH, Mass. & BERLIN & YOKNEAM ILIT, Israel --(BUSINESS WIRE)--Jun. 10, 2022-- ReWalk Robotics Ltd. (Nasdaq: RWLK), (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities,

ReWalk Robotics Announces Share Repurchase Program

06/02/22

MARLBOROUGH, Mass.   BERLIN and YOKNEAM ILIT, Israel , June 02, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that its Board of Directors

ReWalk Robotics Files Revised Preliminary Proxy Statement and Issues Letter to Shareholders

05/26/22

         Highlights the Company’s Recent Progress and Momentum Towards Value-Enhancing Commercialization and Reimbursement Notes that Current Board and Management Team Have the Right Skill Sets, Institutional Knowledge and Third-Party Relationships to Implement Reimbursement Coverage and Create

ReWalk Robotics Confirms Receipt of Director Candidate Nominations from Creative Value Capital

05/19/22

Shareholders Are Not Required to Take Action at This Time MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , May 19, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity

ReWalk Robotics Reports First Quarter 2022 Financial Results

05/13/22

CMS Healthcare Common Procedure Coding System (HCPCS) Public Meeting Agenda includes the ReWalk Exoskeleton MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , May 13, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results

ReWalk Robotics to Report First Quarter 2022 Financial Results on May 13, 2022

05/09/22

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , May 09, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2022 financial results on Friday, May 13, 2022 , after the U.S.

ReWalk Joins Israeli Technology Innovation Consortium for Human-Robot Interaction

04/29/22

The MAGNET Consortium program led by Israel’s Innovation Authority fosters collaboration through R&D grants MARLBOROUGH, Mass. , April 29, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with